Short answer
SELLAS Life Sciences Group, Inc. (SLS) filed an 8-K current report with the SEC on May 12, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). SELLAS reported financial results for the quarter ended March 31, 2026.
SELLAS Life Sciences Group, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- SELLAS reported financial results for the quarter ended March 31, 2026
- May 12, 2026 press release included corporate updates and detailed results
- Exhibit 99.1 contains the substantive financial information for investor review
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other SELLAS Life Sciences Group, Inc. 8-K filings
Get the next SLS 8-K as it lands
Follow SLS for push alerts, or ask the research agent what this filing means.